StemCell Therapy

PUBLIC RELEASE DATE:

12-Aug-2014

Contact: Meng Zhao eic@nrren.org 86-138-049-98773 Neural Regeneration Research

Mammalian adult central nerve system (CNS) injuries are devastating because of the intrinsic difficulties for effective neuronal regeneration. The greatest problem to be overcome for CNS recovery is the poor regeneration of neurons and myelin-forming cells, oligodendrocytes. Endogenous neural progenitors and transplanted exogenous neuronal stem cells can be the source for neuronal regeneration. However, because of the harsh local microenvironment, they usually have very low efficacy for functional neural regeneration which cannot compensate for the loss of neurons and oligodendrocytes. Glial cells (including astrocytes, microglia, oligodendrocytes and NG2 glia) are the majority of cells in CNS that provide support and protection for neurons. Inside the local microenvironment, glial cells largely influence local and transplanted neural stem cells survival and fates. This review critically analyzes current finding of the roles of glial cells in CNS regeneration, and highlights strategies for regulating glial cells' behavior to create a permissive microenvironment for neuronal stem cells. The Perspectives paper published in Neural Regeneration Research (Vol. 9, No. 13, 2014).

###

Article: "Stem cell therapy for central nerve system injuries: glial cells hold the key" by Li Xiao, Chikako Saiki, Ryoji Ide (1 Pharmacology Department, The Nippon Dental University, School of Life Dentistry at Tokyo, Tokyo, Japan; 2 Physiology Department, The Nippon Dental University, School of Life Dentistry at Tokyo, Tokyo, Japan).

Xiao L, Saiki C, Ide R. Stem cell therapy for central nerve system injuries: glial cells hold the key. Neural Regen Res. 2014;9(13):1253-1260.

Contact: Meng Zhao eic@nrren.org 86-138-049-98773 Neural Regeneration Research http://www.nrronline.org/

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Link:
Stem cell therapy for central nerve system injuries: Glial cells hold the key

ARTAS FUE Hair Transplant and Stem Cell Therapy
Dr. William Yates speaks with another happy patient showing great results after a 2000 graft hair transplant utilizing the ARTAS FUE Robotic Hair Transplant ...

By: William Yates

Read the original here:
ARTAS FUE Hair Transplant and Stem Cell Therapy - Video

Beverly Hills, California (PRWEB) August 11, 2014

Nationally recognized Beverly Hills orthopedic surgeon, Dr. Raj, is now offering stem cell procedures to help patients avoid the need for surgery. This may include joint replacement along with tendon or ligament surgery. For more information on stem cell therapy and scheduling at the Beverly Hills Orthopedic Institute, call (310) 247-0466.

As the benefit of stem cells for repair and regeneration of human tissue has evolved, the opportunity to avoid surgery has too. This includes those with cartilage degeneration, tendonitis and ligament injury. Dr. Raj has been a pioneer in bringing stem cell therapies to the forefront, and is now offering the procedures to all patients.

According to Celebrity Fitness Expert Dr. Raj, a nationally recognized Double Board Certified Orthopedic Surgeon at the Beverly Hills Orthopedic Institute, stem cell injections are being used to heal conditions that used to require surgery. Dr. Raj has been featured on The Doctors, SPIKE TV, NBC, CBS, Martha Stewart Living Radio, Beverly Hills Times and has been named Best of LA by KCAL 9 as well we making Americas Top Orthopedics List in 2007, 2009, 2010, and 2011.

Dr. Raj explains that stem cells have started a medical revolution and have altered the way doctors approach treatment. Stem cells help to regenerate the damaged cartilage within a joint and allow patients to take a more conservative route, adds Dr. Raj. Surgery should be a last case scenario after all other options have been exhausted.

For those individuals suffering from joint arthritis of the hip, knee, shoulder or ankle, surgery is an elective decision with nonsurgical options that traditionally did not alter the course of arthritis. They have merely acted as a "band aid" for pain relief, but not effective at long term relief due to healing arthritis.

Stem cell therapy offers the opportunity for relief and increased activity, while staying out of the operating room. The procedures are outpatient and safe, with minimal risks involved.

For more information on the stem cell procedures provided with the top orthopedic doctor in Los Angeles and Beverly Hills, call (310) 247-0466.

See more here:
Nationally Recognized Beverly Hills Orthopedic Surgeon, Dr. Raj, Now Offering Stem Cell Procedures to Help Patients ...

(PRWEB UK) 11 August 2014

BioEden the specialist tooth stem cell bank calls for a more intelligent approach, transparency and public education regarding stem cell banking.

"The public needs to be made aware that the success of stem cell medicine is largely dependant on the right material being available at the right time," says Tony Veverka Group CEO of the rapidly expanding specialist bank.

"With 1 in 3 people predicted to use stem cell therapy within their lifetime people need to know what their choices are at a time when they are able to do something about it, for example obtaining stem cells from their childrens naturally shed baby teeth."

BioEden pioneered the banking of stem cells from childrens baby teeth in 2006 in Austin Texas, and now operates in 21 countries.

BioEden says its unique process has many advantages over other forms and sources of stem cells, and eliminates the costly and painful process of getting stem cells from bone marrow for example.

The BioEden process is patent protected and offers the most natural form of stem cell banking that exists today.

"It is nonsense to say that a dental surgeon needs to extract a childs baby tooth in order to get the best result. The tooth falls out naturally and providing the stem cell bank offers quality transportation and processing, not even dental intervention is required," says Mr Veverka.

There are significant advantages in banking stem cells from teeth over cord blood for example, including the potential for a much wider therapeutic application, its non-invasive, not limited to the number of cells such as with cord blood during the birthing process, and is the least expensive form of private banking there is.

Banking your child's cells is the only way of ensuring a perfect stem cell match, eliminating the emotional distress caused when no match can be found.

See more here:
BioEden calls for transparancy and education on stem cell availability

(PRWEB UK) 9 August 2014

Stem cell therapy and treatments continue to move on in finding cures for diseases that in the past were thought to be incurable. The success of stem cell treatment and therapy relies to a great extent on the ability for the patient to have a stem cell match. Although stem cell banking has been available for a number of years, the cost for many has been a barrier.

Specialist stem cell bank BioEden who operate in 21 countries have come up with a solution that brings this potentially life saving opportunity within an affordable range for the majority.

Their aim is to make stem cell therapy an affordable reality and hope that their new approach which includes a low monthly membership option will do just that.

As more and more people bank their children's stem cells for their future use, the problem of finding a stem cell match could become a thing of the past.

Go here to see the original:
Due to a radical new approach by stem cell bank BioEden future generations could be guaranteed a stem cell match

Stem Cell Therapy - Am I A Candidate
Farhan Saddiqi, MD discusses the process of determining whether you are a candidate for Stem Cell Therapy at the Trinity Stem Cell Institute.

By: SMU Productions - Tampa Video Production

Excerpt from:
Stem Cell Therapy - Am I A Candidate - Video

Kasi kaka-quit ko lang ng smoking, Lorna Tolentino proudly announces.

The 52-year-old actress also adds, Mag-wa-one month na sa August 14.

Asked whether shes having a hard time adjusting her lifestyle, she says, Ay no, hindi naman talaga ako ganun Im not really talaga sobrang sobrang smoker.

Right now, Lorna is taking supplements such as vitamin B1, B complex, glutathione, and mangosteen and malunggay capsules.

Siyempre nung nag-50 ako, mas iniisip ko na mas tumagal pa.

Kasi siyempre, 'di ba, gone too soon si Rudy [Fernandez], kaya siyempre kailangan mas mahaba pa, lalo na because of my apo, yun ang nag-i-inspire sa akin, she confesses.

When asked whether shes ok with Lyla Victoria, Raphael's (Lorna's eldest son) daughter, entering showbiz, Lorna answers, Commercial kung meron, oo tatangapin ko.

Lorna enthusiastically talks about her two-year-old apo, whom she refers to as still being in her makulit stage, Shes ok, actually yung kanya intellectual [maturity] ano, something na pinapaano sa mga doctor, for four years old na.

She also complements Leana, Lylas mother, for teaching her grandchild, Talagang kinu-congratulate ko si Leana, because shes a teacher, talagang mas kaya niya i-guide.

STEM CELL THERAPY.Lorna Tolentino, who has undergone stem cell therapy, narrates how the procedure helped her health concerns.

Here is the original post:
Lorna Tolentino reveals the secret to her youthful looks

A stroke therapy using stem cells extracted from patients' bone marrow has shown promising results in the first trial of its kind in humans.

Five patients received the treatment in a pilot study conducted by doctors at Imperial College Healthcare NHS Trust and scientists at Imperial College London.

The therapy was found to be safe, and all the patients showed improvements in clinical measures of disability.

The findings are published in the journal Stem Cells Translational Medicine. It is the first UK human trial of a stem cell treatment for acute stroke to be published.

The therapy uses a type of cell called CD34+ cells, a set of stem cells in the bone marrow that give rise to blood cells and blood vessel lining cells. Previous research has shown that treatment using these cells can significantly improve recovery from stroke in animals. Rather than developing into brain cells themselves, the cells are thought to release chemicals that trigger the growth of new brain tissue and new blood vessels in the area damaged by stroke.

The patients were treated within seven days of a severe stroke, in contrast to several other stem cell trials, most of which have treated patients after six months or later. The Imperial researchers believe early treatment may improve the chances of a better recovery.

A bone marrow sample was taken from each patient. The CD34+ cells were isolated from the sample and then infused into an artery that supplies the brain. No previous trial has selectively used CD34+ cells, so early after the stroke, until now.

Although the trial was mainly designed to assess the safety and tolerability of the treatment, the patients all showed improvements in their condition in clinical tests over a six-month follow-up period.

Four out of five patients had the most severe type of stroke: only four per cent of people who experience this kind of stroke are expected to be alive and independent six months later. In the trial, all four of these patients were alive and three were independent after six months.

Dr Soma Banerjee, a lead author and Consultant in Stroke Medicine at Imperial College Healthcare NHS Trust, said: "This study showed that the treatment appears to be safe and that it's feasible to treat patients early when they might be more likely to benefit. The improvements we saw in these patients are very encouraging, but it's too early to draw definitive conclusions about the effectiveness of the therapy. We need to do more tests to work out the best dose and timescale for treatment before starting larger trials."

See original here:
Stem cells show promise for stroke in pilot study

PHYTOSCIENCE PHILIPPINES DOUBLE SKIN CELL THERAPY REVIEW
PHYTOSCIENCE PHILIPPINES DOUBLE SKIN CELL THERAPY REVIEW A RARE OPPORTUNITY TO ALL FILIPINOS BE A PART OF THE PHYTOSCIENCE PIONEERING TEAM 2013 Best Selling ...

By: phytoscience double stem cell philippines

Excerpt from:
PHYTOSCIENCE PHILIPPINES DOUBLE SKIN CELL THERAPY REVIEW - Video

(PRWEB UK) 7 August 2014

BioEden the specialist tooth stem cell bank stands by its pledge to make personalised stem cell therapy an affordable reality by launching Access Membership at just 5 per month.

With stem cell therapy holding the promise of longer and better lives in the future, the cost and the ease of finding a stem cell match has been an issue, given that the cost of private stem cell banking requires an initial cash outlay of up to 4000.

Not any more.

BioEden the leading specialist tooth stem cell bank, has added Access Membership to parents finding themselves financially unable to bank their child's cells for future use. "It doesnt sit well with us that a parent could be unable to access what could be a life saving service for their child, for financial reasons," said Group CEO Mr Tony Veverka.

Parents can access the stem cell banking service for just 5 per month, and can become a member of the plan as soon as the baby is born. To date the option for stem cell banking at birth has been umbilical cord blood banking, an invasive process which provides haemopoetic stem cell banking at a cost.

Now parents have the option to choose tooth stem cell banking or to add this to cord blood banking at a very low monthly cost.

Tooth stem cells have considerable advantages over cord blood cells;

And now, thanks to BioEden, cost doesnt have to be a barrier.

So how can 5 a month give access to such a specialist service?

Read the original post:
BioEden fights the financial cost of stem cell banking by bringing their specialist service to the people for just 5 ...

Dr. A.P.REYES~U.S. SENATOR-LEGALIZING STEM CELL THERAPY
I created this video with the YouTube Slideshow Creator (http://www.youtube.com/upload)

By: Arturo Reyes

Continue reading here:
Dr. A.P.REYES~U.S. SENATOR-LEGALIZING STEM CELL THERAPY - Video

LEGALIZING STEM CELL THERAPY in the U.S.A. By: Dr. Arturo Pacheco Reyes, MD U.S. Senator
I created this video with the YouTube Slideshow Creator (http://www.youtube.com/upload)

By: Arturo Reyes

More:
LEGALIZING STEM CELL THERAPY in the U.S.A. By: Dr. Arturo Pacheco Reyes, MD U.S. Senator - Video

Dr Felix new protocol on Stem Cell therapy
Dr. FELIX molecular biologist , medical doctor developed world first protocol using peptides with Stem Cell therapy to improve patients outcome.

By: Soraya Felix

Continue reading here:
Dr Felix new protocol on Stem Cell therapy - Video

What clinical trials for gene and stem cell therapy are under way in your London laboratory?
Robin Ali, BSc, PhD, FMedSci, internationally known for his research in gene and cell-based therapy for the treatment of retinal degeneration, has joined the U-M Department of Ophthalmology...

By: Kellogg Eye Center - Ann Arbor

Continued here:
What clinical trials for gene and stem cell therapy are under way in your London laboratory? - Video

What is Okyanos Cardiac Stem Cell Therapy?
Cardiac stem cell therapy is a promising new treatment option for advanced heart disease patients. This short video explores the procedure and benefits of adult stem cell therapy for severe...

By: Okyanos Heart Institute

Continue reading here:
What is Okyanos Cardiac Stem Cell Therapy? - Video

Tampa Bay, FL (PRWEB) July 28, 2014

Nearly 53 million Americans today are suffering with arthritis, with the majority of them diagnosed with osteoarthritis. (1) Osteoarthritis is a degeneration of joint cartilage and its underlying bone, causing significant pain and stiffness. While osteoarthritis has no cure, stem cell therapy has been demonstrated to induce profound healing in many forms of arthritis, according to the Stem Cell Institute. (2) Dr. Cynthia Elliott of Skinspirations, a center for cosmetic enhancement devoted to non-surgical aesthetics and now also specializing in administering regenerative medicine by stem cell, has made use of these services in a recent case study, which resulted in improved health in one of their clients.

Stem cells are unique from other cells for the following reasons:

(a)They can renew themselves through cell division; and (b)Under certain conditions, they can become tissue or organ-specific cells.

Stem cells are revered for their ability to make replacement tissues, as it relates to regenerative therapy. (3) Medical scientists and researchers are discovering the seemingly endless possibilities of what stem cells can treat, including brain damage, bone repair, kidney disease, etc. (4) This treatment is starting to boom in the medical world as a viable procedure, but Skinspirations has already had these practices in place, establishing them as progressive practitioners in the field.

Skinspirations is specifically studying the Stromal Vascular Fraction (SVF)another term for stem cell treatmentand how it affects knees with severe arthritis. According to Dr. Elliott, Stromal Vascular Fraction can help to repair, replace and restore any damaged cells within the bodyDr. Elliott performed the stem cell procedure on her uncle after first treating other patients during her training, and he experienced the following results:

Case in Point:

Joe Elliott, a 63-year-old male, had severe arthritis in one knee. Doctors advised him to get a knee replacement, but Joe was hoping to avoid surgery for as long as possible. After talking to Dr. Elliott about the treatment, he drove to Skinspirations from Missouri to go forward with the stem cell procedure.

Dr. Elliott performed the treatment with the following steps:

(1)Numbed his abdomen with anesthesia; (2)Removed about 100 cc of fat; (3)Processed the fat to isolate the SVF; (4)Numbed the arthritic knee; and (5)Injected the pellet of SVF into the joint of his arthritic knee.

Read more from the original source:
Skinspirations Study Supports Medical Findings: Stem Cell Treatment Triggers Tissue Regeneration

STEM CELL THERAPY SUPERNOVA
We implant EMBRYONIC STEM CELLS from our STEM CELL BANK This is state-of-the-art ADVANTAGE for it eliminates the suffering and pain from liposuction(fat removal) or bone marrow extraction,...

By: Leong Lau

Read the original post:
STEM CELL THERAPY SUPERNOVA - Video

PUBLIC RELEASE DATE:

24-Jul-2014

Contact: David McKeon dmckeon@nyscf.org 212-365-7440 New York Stem Cell Foundation

NEW YORK, NY (July 24, 2014) Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.

For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they developed an accelerated protocol to induce these stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system implicated in multiple sclerosis and many other diseases.

Existing protocols for producing oligodendrocytes had taken almost half a year to produce, limiting the ability of researchers to conduct their research. This study has cut that time approximately in half, making the ability to utilize these cells in research much more feasible.

Stem cell lines and oligodendrocytes allow researchers to "turn back the clock" and observe how multiple sclerosis develops and progresses, potentially revealing the onset of the disease at a cellular level long before any symptoms are displayed. The improved protocol for deriving oligodendrocyte cells will also provide a platform for disease modeling, drug screening, and for replacing the damaged cells in the brain with healthy cells generated using this method.

"We are so close to finding new treatments and even cures for MS. The enhanced ability to derive the cells implicated in the disease will undoubtedly accelerate research for MS and many other diseases," said Susan L. Solomon, NYSCF Chief Executive Officer.

"We believe that this protocol will help the MS field and the larger scientific community to better understand human oligodendrocyte biology and the process of myelination. This is the first step towards very exciting studies: the ability to generate human oligodendrocytes in large amounts will serve as an unprecedented tool for developing remyelinating strategies and the study of patient-specific cells may shed light on intrinsic pathogenic mechanisms that lead to progressive MS". said Dr. Valentina Fossati, NYSCF Helmsley Investigator and senior author on the paper.

In multiple sclerosis, the protective covering of axons, called myelin, becomes damaged and lost. In this study, the scientists not only improved the protocol for making the myelin-forming cells but they showed that the oligodendrocytes derived from the skin of primary progressive patients are functional, and therefore able to form their own myelin when put into a mouse model. This is an initial step towards developing future autologous cell transplantation therapies in multiple sclerosis patients

Go here to read the rest:
NYSCF scientists one step closer to cell therapy for multiple sclerosis patients

San Diego, CA (PRWEB) July 25, 2014

WABC Radio show out of New York City, A Paws For Your Pet with Lorry Young will be hosting California-based Vet-Stem, Inc.s Founder and CEO, Robert J. Harman, DVM, to talk about stem cell therapy in pets. Dr. Harman first visited the show in November 2013 to discuss the benefits of stem cell therapy for pets suffering from osteoarthritis and other degenerative diseases, as well as recent developments moving the Regenerative Veterinary Medicine industry forward.

Young has invited Dr. Harman back to dial down into specific case studies and success stories of the over 10,000 dogs, cats, horses and exotic animals that Vet-Stems services have treated in the last decade. Moose, a Labrador Retriever Mix, is one of those special pet patients in the New York City area that was treated with Vet-Stem Regenerative Cell Therapy for arthritis caused by elbow dysplasia, and arthritic bone growth.

When Mooses owners noticed decreased mobility, lameness, and an increasingly lower tolerance for other dogs they brought Moose to local veterinarian Alex Klein to explore solutions. As many as 65% of dogs between the ages of 7 and 11 years old are inflicted with some degree of arthritis. Certain specific breeds, much like Moose, are reported to have as high of a percentage as 70 in being diagnosed with arthritis.

Stem cell therapy has been proven to help with the pain of arthritis in pets because it decreases inflammation, regenerates damaged tissues, and restores range of motion. An owner survey showed that greater than 80% of dogs treated for osteoarthritis in one or more leg joints with Vet-Stem Regenerative Cell Therapy showed an improved quality of life. Dogs like Moose have a small amount of fat collected by their veterinarian, which is sent overnight to Vet-Stems lab. There, the fat is separated from the stem cells and injectable doses of concentrated stem cells are sent back to the veterinarian overnight. Within 48 hours Moose received injections in his arthritic joints and the healing process began.

This ability to improve on a pets quality of life is why Dr. Harman is so passionate about sharing stories with other animal enthusiasts such as Young and her radio audience. Pet-spert, Young offers a special look into the latest techniques, treatments, and options that will enable listeners to provide their pets with a safer, healthier, and happier life. Produced and hosted by Young, A Paws For Your Pet, helps listeners answer any potential questions they may have regarding the health and well-being of their beloved pet, and hosts experts in the industry like Dr. Harman regularly.

About Vet-Stem, Inc. Since its formation in 2002, Vet-Stem, Inc. has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem pioneered the use of regenerative stem cells for horses, dogs, cats, and some exotics. In 2004 the first horse was treated with Vet-Stem Regenerative Cell Therapy for a tendon injury that would normally have been career ending. Ten years later Vet-Stem celebrated its 10,000th animal treated, and the success of establishing stem cell therapy as a proven regenerative medicine for certain inflammatory, degenerative, and arthritic diseases. As animal advocates, veterinarians, veterinary technicians, and cell biologists, the team at Vet-Stem tasks themselves with the responsibility of discovering, refining, and bringing to market innovative medical therapies that utilize the bodys own healing and regenerative cells. For more information about Vet-Stem and Regenerative Veterinary Medicine visit http://www.vet-stem.com or call 858-748-2004.

Read this article:
Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode ...

July 24, 2014, 10:29 p.m.

A 60 MINUTES report on new multiple sclerosis stem cell therapy has thrown Wendouree mum Kathryn Johnston a potential lifeline.

A 60 MINUTES report on new multiple sclerosis stem cell therapy has thrown Wendouree mum Kathryn Johnston a potential lifeline.

Hopeful: Wendouree mum Kathryn Johnston is hoping new stem cell therapy treatment will help her be a more active mother to her daughter Dellah, 7. PICTURE: KATE HEALY

Ms Johnston, who has had MS for 15 years, is hoping the treatment will help her be a more active mother to daughter Dellah, 7.

I cant do a great deal with my daughter now but its also the unknown not knowing if Ill wake up one day and not be able to walk, Ms Johnston said.

The 35-year-old emergency nurse hopes to travel to Russia in August next year for the treatment, which involves extracting her stem cells, freezing them while she undergoes a strong course of chemotherapy and then replacing them.

It gets rid of any underlying MS and rebuilds the immune system from scratch. As a general rule, its been about 80 per cent effective.

Ms Johnston first noticed her MS symptoms as an active Ararat 20-year-old doing her nursing degree and about to marry her childhood sweetheart Andrew.

I developed numbness in both hands but thought Id just slept on them until my tummy went numb too.

More here:
MS stem cell therapy treatment hope for mum